Challenges in therapy of chronic hepatitis B

被引：6

作者：

Hoofnagle, JH ^{[1
]}

机构：

[1] NIDDKD, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF HEPATOLOGY | 2003年 / 39卷

关键词：

D O I：

10.1016/S0168-8278(03)00332-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：S230 / S235

页数：6

相关论文

共 22 条

[1]

DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629

[2]

HEPATITIS-B VIRUS DEOXYRIBONUCLEIC-ACID IN LIVER OF CHRONIC CARRIERS - CORRELATION WITH SERUM MARKERS AND CHANGES ASSOCIATED WITH LOSS OF HEPATITIS-B-E ANTIGEN AFTER ANTIVIRAL THERAPY [J].

DIBISCEGLIE, AM ;

WAGGONER, JG ;

HOOFNAGLE, JH .

GASTROENTEROLOGY, 1987, 93 (06) :1236-1241

[3]

A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[4]

Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

[5]

A RANDOMIZED CONTROLLED TRIAL OF LYMPHOBLASTOID INTERFERON-ALPHA IN PATIENTS WITH CHRONIC HEPATITIS-B LACKING HBEAG [J].

FATTOVICH, G ;

FARCI, P ;

RUGGE, M ;

BROLLO, L ;

MANDAS, A ;

PONTISSO, P ;

GIUSTINA, G ;

LAI, ME ;

BELUSSI, F ;

BUSATTO, G ;

BALESTRIERI, A ;

RUOL, A ;

ALBERTI, A .

HEPATOLOGY, 1992, 15 (04) :584-589

[6]

PERSISTENCE OF HEPATITIS-B VIRUS-DNA IN THE LIVER AFTER LOSS OF HBSAG IN CHRONIC HEPATITIS-B [J].

FONG, TL ;

DIBISCEGLIE, AM ;

GERBER, MA ;

WAGGONER, JG ;

HOOFNAGLE, JH .

HEPATOLOGY, 1993, 18 (06) :1313-1318

[7]

Ghany MG, 2000, HEPATOLOGY, V32, p376A, DOI 10.1053/jhep.2000.17912

[8]

EFFECT OF HUMAN LEUKOCYTE INTERFERON ON HEPATITIS B VIRUS-INFECTION IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS [J].

GREENBERG, HB ;

POLLARD, RB ;

LUTWICK, LI ;

GREGORY, PB ;

ROBINSON, WS ;

MERIGAN, TC .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (10) :517-522

[9]

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Tassopoulos, NC ;

Heathcote, EJ ;

Chang, TT ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807

[10]

Sustained antiviral response and lack of viral resistance with long term adefovir dipivoxil (ADV) therapy in chronic HBV infection [J].

Heathcote, E ;

Jeffers, L ;

Perrillo, R ;

Wright, T ;

Sherman, M ;

Namini, H ;

Xiong, S ;

James, C ;

Ho, V ;

Fry, J ;

Brosgart, C .

JOURNAL OF HEPATOLOGY, 2002, 36 :110-111